+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lamisil"

Onychomycosis Treatment Market Report 2025 - Product Thumbnail Image

Onychomycosis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Lamisil is an antifungal medication used to treat a variety of fungal infections, including those caused by dermatophytes, yeasts, and molds. It is commonly used to treat infections of the skin, nails, and scalp, as well as fungal infections of the mouth, throat, and lungs. Lamisil is part of the Infectious Diseases Drugs market, which includes medications used to treat a variety of bacterial, viral, and fungal infections. These drugs are used to treat a wide range of infections, from minor skin infections to life-threatening illnesses. The Infectious Diseases Drugs market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Johnson & Johnson. Other companies in the market include Bayer, Sanofi, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more